Identifying an accurate self-reported screening tool for alcohol use disorder: evidence from a Swiss, male population-based assessment.


Journal

Addiction (Abingdon, England)
ISSN: 1360-0443
Titre abrégé: Addiction
Pays: England
ID NLM: 9304118

Informations de publication

Date de publication:
03 2020
Historique:
received: 11 04 2019
revised: 21 06 2019
accepted: 14 10 2019
pubmed: 28 10 2019
medline: 20 2 2021
entrez: 28 10 2019
Statut: ppublish

Résumé

Short screenings for alcohol use disorder (AUD) are crucial for public health purposes, but current self-reported measures have several pitfalls and may be unreliable. The main aim of our study was to provide empirical evidence on the psychometric performance of self-reports currently used. Our research questions were: compared with a gold standard clinical interview, how accurate are (1) self-reported AUD, (2) self-reported alcohol use over time and (3) biomarkers of alcohol use among Swiss men? Finally, we aimed to identify an alternative screening tool. A single-center study with a cross-sectional design and a stratified sample selection. Lausanne University Hospital (Switzerland) from October 2017 to June 2018. We selected participants from the French-speaking participants of the ongoing Cohort Study on Substance Use and Risk Factors (n = 233). The sample included young men aged on average 27.0 years. We used the Diagnostic Interview for Genetic Studies as the gold standard for DSM-5 AUD. The self-reported measures included 11 criteria for AUD, nine alcohol-related consequences, and previous 12 months' alcohol use. We also assessed biomarkers of chronic excessive drinking (ethyl glucuronide and phosphatidylethanol). None of the self-reported measures/biomarkers taken alone displayed both sensitivity and specificity close to 100% with respect to the gold standard (e.g. self-reported AUD: sensitivity = 92.3%, specificity = 45.8%). The best model combined eight self-reported criteria of AUD and four alcohol-related consequences. Using a cut-off of three, this screening tool yielded acceptable sensitivity (83.3%) and specificity (78.7%). Neither self-reported alcohol use disorder nor heavy alcohol use appear to be adequate to screen for alcohol use disorder among young men from the Swiss population. The best screening alternative for alcohol use disorder among young Swiss men appears to be a combination of eight symptoms of alcohol use disorder and four alcohol-related consequences.

Sections du résumé

BACKGROUND AND AIMS
Short screenings for alcohol use disorder (AUD) are crucial for public health purposes, but current self-reported measures have several pitfalls and may be unreliable. The main aim of our study was to provide empirical evidence on the psychometric performance of self-reports currently used. Our research questions were: compared with a gold standard clinical interview, how accurate are (1) self-reported AUD, (2) self-reported alcohol use over time and (3) biomarkers of alcohol use among Swiss men? Finally, we aimed to identify an alternative screening tool.
DESIGN
A single-center study with a cross-sectional design and a stratified sample selection.
SETTING
Lausanne University Hospital (Switzerland) from October 2017 to June 2018.
PARTICIPANTS
We selected participants from the French-speaking participants of the ongoing Cohort Study on Substance Use and Risk Factors (n = 233). The sample included young men aged on average 27.0 years.
MEASUREMENTS
We used the Diagnostic Interview for Genetic Studies as the gold standard for DSM-5 AUD. The self-reported measures included 11 criteria for AUD, nine alcohol-related consequences, and previous 12 months' alcohol use. We also assessed biomarkers of chronic excessive drinking (ethyl glucuronide and phosphatidylethanol).
FINDINGS
None of the self-reported measures/biomarkers taken alone displayed both sensitivity and specificity close to 100% with respect to the gold standard (e.g. self-reported AUD: sensitivity = 92.3%, specificity = 45.8%). The best model combined eight self-reported criteria of AUD and four alcohol-related consequences. Using a cut-off of three, this screening tool yielded acceptable sensitivity (83.3%) and specificity (78.7%).
CONCLUSIONS
Neither self-reported alcohol use disorder nor heavy alcohol use appear to be adequate to screen for alcohol use disorder among young men from the Swiss population. The best screening alternative for alcohol use disorder among young Swiss men appears to be a combination of eight symptoms of alcohol use disorder and four alcohol-related consequences.

Identifiants

pubmed: 31656049
doi: 10.1111/add.14864
doi:

Substances chimiques

Biomarkers 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

426-436

Subventions

Organisme : Swiss National Research Foundation
ID : 10001C_173418/1
Pays : International

Informations de copyright

© 2019 Society for the Study of Addiction.

Références

American Psychiatric Association (APA) Diagnostic and Statistical Manual of Mental Disorders, 4th edn. Washington, DC: APA; 2000.
Rehm J. How should prevalence of alcohol use disorders be assessed globally? Int J Methods Psychiatr Res 2016; 25: 79-85.
World Health Organization (WHO) ICD-10 Classification of Mental and Behavioral Disorder: Clinical Descriptions and Diagnostics Guidelines. Geneva: Switzerland: WHO; 1992.
American Psychiatric Publishing Diagnostic and Statistical Manual of Mental Disorders, 5th edn. Arlington, VA: American Psychiatric Publishing; 2013.
Baggio S., Studer J., Dupuis M., Gerhard G. Subthreshold problem drinkers in DSM-5 alcohol use disorder classification. Am J Addict 2016; 25: 408-415.
Hasin D. S., O'Brien C. P., Auriacombe M., Borges G., Bucholz K., Budney A., et al. DSM-5 criteria for substance use disorders: recommendations and rationale. Am J Psychiatry 2013; 170: 834-851.
Lundin A., Hallgren M., Forsman M., Forsell Y. Comparison of DSM-5 classifications of alcohol use disorders with those of DSM-IV, DSM-III-R, and ICD-10 in a general population sample in Sweden. J Stud Alcohol Drugs 2015; 76: 773-780.
Bartoli F., Carrà G., Crocamo C., Clerici M. From DSM-IV to DSM-5 alcohol use disorder: an overview of epidemiological data. Addict Behav 2015; 41: 46-50.
Mohler-Kuo M., Foster S., Gmel G., Dey M., Dermota P. DSM-IV and DSM-5 alcohol use disorder among young Swiss men. Addiction 2015; 110: 429-440.
Marmet S., Studer J., Bertholet N., Grazioli V. S., Daeppen J.-B., Gmel G. Interpretation of DSM-5 alcohol use disorder criteria in self-report surveys may change with age. A longitudinal analysis of young Swiss men. Addict Res Theory 2019; 0: 1-9.
Karriker-Jaffe K. J., Witbrodt J., Greenfield T. K. Refining measures of alcohol problems for general population surveys. Alcohol Clin Exp Res 2015; 39(2): 363-370.
Slade T., Teesson M., Mewton L., Memedovic S., Krueger R. F. Do young adults interpret the DSM diagnostic criteria for alcohol use disorders as intended? A cognitive interviewing study. Alcohol Clin Exp Res 2013; 37: 1001-1007.
Lane S. P., Steinley D., Sher K. J. Meta-analysis of DSM alcohol use disorder criteria severities: structural consistency is only ‘skin deep’. Psychol Med 2016; 46: 1769-1784.
Nutt D. J., Rehm J. Doing it by numbers: a simple approach to reducing the harms of alcohol. J Psychopharmacol (Oxf) 2014; 28: 3-7.
Baggio S., Iglesias K., Studer J., Dupuis M., Daeppen J.-B., Gmel G. Is the relationship between major depressive disorder and self-reported alcohol use disorder an artificial one? Alcohol Alcohol 2015; 50: 195-199.
Rehm J., Marmet S., Anderson P., Gual A., Kraus L., Nutt D. J., et al. Defining substance use disorders: do we really need more than heavy use? Alcohol Alcohol 2013; 48: 633-640.
Saha T. D., Stinson F. S., Grant B. F. The role of alcohol consumption in future classifications of alcohol use disorders. Drug Alcohol Depend 2007; 89: 82-92.
Baggio S., Dupuis M., Studer J., Spilka S., Daeppen J.-B., Simon O., et al. Reframing video gaming and internet use addiction: empirical cross-national comparison of heavy use over time and addiction scales among young users. Addiction 2016; 111: 513-522.
Baggio S., N'Goran A. A., Deline S., Studer J., Dupuis M., Henchoz Y., et al. Patterns of cannabis use and prospective associations with health issues among young males. Addiction 2014; 109: 937-945.
Király O., Tóth D., Urbán R., Demetrovics Z., Maraz A. Intense video gaming is not essentially problematic. Psychol Addict Behav 2017; 31: 807-817.
Department of Health Alcohol guidelines review - Report from the Guidelines development group to the UK chief medical officers. London, UK: Department of Health; 2016.
Wood A. M., Kaptoge S., Butterworth A. S., Willeit P., Warnakula S., Bolton T., et al. Risk thresholds for alcohol consumption: combined analysis of individual-participant data for 599 912 current drinkers in 83 prospective studies. Lancet 2018; 391: 1513-1523.
Cabarcos P., Álvarez I., Tabernero M. J., Bermejo A. M. Determination of direct alcohol markers: a review. Anal Bioanal Chem 2015; 407: 4907-4925.
Society of Hair Testing Consensus for the Use of Alcohol Markers in Hair for Assessment of Both Abstinence and Chronic Excessive Alcohol Consumption. Brisbane: Australia: Society of Hair Testing; 2016.
Japuntich S. J., Arditte Hall K. A., Joos C. M., Rasmusson A. M., Pineles S. L. Methods to reduce false reporting of substance abstinence in clinical research. Int J Methods Psychiatr Res 2018; 27: e1603.
Hahn J. A., Anton R. F., Javors M. A. The formation, elimination, interpretation and future research needs of phosphatidylethanol (PEth) for research studies and clinical practice. Alcohol Clin Exp Res 2016; 40: 2292-2295.
Kharbouche H., Faouzi M., Sanchez N., Daeppen J. B., Augsburger M., Mangin P., et al. Diagnostic performance of ethyl glucuronide in hair for the investigation of alcohol drinking behavior: a comparison with traditional biomarkers. Int J Leg Med 2012; 126: 243-250.
Schröck A., Wurst F. M., Thon N., Weinmann W. Assessing phosphatidylethanol (PEth) levels reflecting different drinking habits in comparison to the alcohol use disorders identification test-C (AUDIT-C). Drug Alcohol Depend 2017; 178: 80-86.
Iglesias K., Sporkert F., Daeppen J.-B., Gmel G., Baggio S. Comparison of self-reported measures of alcohol-related dependence among young Swiss men: a study protocol for a cross-sectional controlled sample. BMJ Open 2018; 8: e023632.
Gmel G., Akre C., Astudillo M., Bähler C., Baggio S., Bertholet N., et al. The Swiss cohort study on substance use risk factors-findings of two waves. Sucht 2015; 61: 251-262.
Studer J., Baggio S., Mohler-Kuo M., Dermota P., Gaume J., Bertholet N., et al. Examining non-response bias in substance use research-are late respondents proxies for non-respondents? Drug Alcohol Depend 2013; 132: 316-323.
Knight J. R., Wechsler H., Kuo M., Seibring M., Weitzman E. R., Schuckit M. A. Alcohol abuse and dependence among U.S. college students. J Stud Alcohol 2002; 63: 263-270.
Meneses-Gaya C., Zuardi A. W., Loureiro S. R., Hallak J. E. C., Trzesniak C., de Azevedo M. J. M., et al. Is the full version of the AUDIT really necessary? Study of the validity and internal construct of its abbreviated versions. Alcohol Clin Exp Res 2010; 34: 1417-1424.
Salazar A. J., Romero J. A., Bernal O. A., Moreno A. P., Velasco S. C., Díaz X. A. Noninferiority and equivalence evaluation of clinical performance among computed radiography, film, and digitized film for telemammography services. Int J Telemed Appl 2016; 2016: 3642960.
Berney A., Preisig M., Matthey M.-L., Ferrero F., Fenton B. T. Diagnostic interview for genetic studies (DIGS): inter-rater and test-retest reliability of alcohol and drug diagnoses. Drug Alcohol Depend 2002; 65: 149-158.
Grant B. F., Dawson D. A., Stinson F. S., Chou P. S., Kay W., Pickering R. The alcohol use disorder and associated disabilities interview schedule-IV (AUDADIS-IV): reliability of alcohol consumption, tobacco use, family history of depression and psychiatric diagnostic modules in a general population sample. Drug Alcohol Depend 2003; 71: 7-16.
Dupuis M., Baggio S., Henchoz Y., Deline S., N'Goran A., Studer J., et al. Risky single occasion drinking frequency and alcohol-related consequences: can abstinence during early adulthood lead to alcohol problems? Swiss Med Wkly 2014; 144: w14017.
Wechsler H., Davenport A., Dowdall G., Moeykens B., Castillo S. Health and behavioral consequences of binge drinking in college. A national survey of students at 140 campuses. JAMA 1994; 272: 1672-1677.
Gmel G., Studer J., Deline S., Baggio S., N'Goran A., Mohler-Kuo M., et al. More is not always better-comparison of three instruments measuring volume of drinking in a sample of young men and their association with consequences. J Stud Alcohol Drugs 2014; 75: 880-888.
Déglon J., Lauer E., Sporkert F., Valois N., Favrat B., Thomas A., et al. Analyse du phosphatidyléthanol Sur micro-prélèvement de sang séché: nouvel outil pour le suivi de la consommation d'alcool. Phosphatidylethanol analysis for micro-sampling dried blood: A new tool for monitoring alcohol use Toxicol Anal Clin 2018; 30: S42-S43.
Youden W. J. Index for rating diagnostic tests. Cancer 1950; 3: 32-35.
van Stralen K. J., Stel V. S., Reitsma J. B., Dekker F. W., Zoccali C., Jager K. J. Diagnostic methods I: sensitivity, specificity, and other measures of accuracy. Kidney Int 2009; 75: 1257-1263.
Steyerberg E. W., Harrell F. E., Borsboom G. J., Eijkemans M. J., Vergouwe Y., Habbema J. D. Internal validation of predictive models: efficiency of some procedures for logistic regression analysis. J Clin Epidemiol 2001; 54: 774-781.
Baggio S., Iglesias K., Rousson V. Modeling count data in the addiction field: some simple recommendations. Int J Methods Psychiatr Res 2018; 27.
Kerridge B. T., Saha T. D., Gmel G., Rehm J. Taxometric analysis of DSM-IV and DSM-5 alcohol use disorders. Drug Alcohol Depend 2013; 129: 60-69.
Liu R. T. Substance use disorders in adolescence exist along continua: Taxometric evidence in an epidemiological sample. J Abnorm Child Psychol 2017; 45: 1577-1586.
Stevens J. E., Steinley D., McDowell Y. E., Boness C. L., Trull T. J., Martin C. S., et al. Toward more efficient diagnostic criteria sets and rules: the use of optimization approaches in addiction science. Addict Behav 2019; 94: 57-64.
Wakefield J. C., Schmitz M. F. The harmful dysfunction model of alcohol use disorder: revised criteria to improve the validity of diagnosis and prevalence estimates. Addiction 2015; 110: 931-942.
Martin C. S., Langenbucher J. W., Chung T., Sher K. J. Truth or consequences in the diagnosis of substance use disorders. Addiction 2014; 109: 1773-1778.
Teesson M., Baillie A. J., Slade T. ‘Truth or consequences’-what about truth or dare. Addiction 2014; 109: 1782-1784.
Charlet K., Heinz A. Harm reduction-a systematic review on effects of alcohol reduction on physical and mental symptoms. Addict Biol 2017; 22: 1119-1159.
Kuntsche E., Gmel G. Alcohol consumption in late adolescence and early adulthood--where is the problem? Swiss Med Wkly 2013; 143: w13826.
Atak H., Cok F. The Turkish version of inventory of the dimensions of emerging adulthood. Int J Hum Soc Sci 2008; 3: 451-457.

Auteurs

Stéphanie Baggio (S)

Division of Prison Health, Geneva University Hospitals and University of Geneva, Thônex, Switzerland.
Department of Forensic Psychiatry, Institute of Forensic Medicine, University of Bern, Bern, Switzerland.

Bastien Trächsel (B)

Division of Biostatistics, Center for Primary Care and Public Health (Unisanté), University of Lausanne, Lausanne, Switzerland.

Valentin Rousson (V)

Division of Biostatistics, Center for Primary Care and Public Health (Unisanté), University of Lausanne, Lausanne, Switzerland.

Stéphane Rothen (S)

Addiction Division, Geneva University Hospitals and University of Geneva, Geneva, Switzerland.

Joseph Studer (J)

Addiction Medicine, Department of Psychiatry, Lausanne University Hospital, Lausanne, Switzerland.

Simon Marmet (S)

Addiction Medicine, Department of Psychiatry, Lausanne University Hospital, Lausanne, Switzerland.

Patrick Heller (P)

Division of Prison Health, Geneva University Hospitals and University of Geneva, Thônex, Switzerland.
Adult Psychiatry Division, Department of Mental Health and Psychiatry, Geneva University Hospitals, Thônex, Switzerland.

Frank Sporkert (F)

Centre of Legal Medicine, Forensic Toxicology and Chemistry Unit, Lausanne and Geneva Universities, Lausanne, Switzerland.

Jean-Bernard Daeppen (JB)

Addiction Medicine, Department of Psychiatry, Lausanne University Hospital, Lausanne, Switzerland.

Gerhard Gmel (G)

Addiction Medicine, Department of Psychiatry, Lausanne University Hospital, Lausanne, Switzerland.
Addiction Switzerland, Lausanne, Switzerland.
Centre for Addiction and Mental Health, Toronto,, ON, Canada.
University of the West of England, Bristol, UK.

Katia Iglesias (K)

School of Health Sciences, HES-SO University of Applied Sciences and Arts of Western Switzerland, Fribourg, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH